Stephan Kontos
Directeur/Bestuurslid bij Aperiam Bio, Inc.
Actieve functies van Stephan Kontos
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Private Equity Investor | 01-10-2022 | - |
Aperiam Bio, Inc.
 Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Directeur/Bestuurslid | 01-03-2022 | - |
Loopbaan van Stephan Kontos
Eerdere bekende functies van Stephan Kontos
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 31-12-2012 | 01-10-2022 |
| Oprichter | - | 01-10-2022 | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Oprichter | 01-01-2015 | - |
Opleiding van Stephan Kontos
| The University of Texas at Austin | Undergraduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Zwitserland | 3 |
Operationeel
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Aperiam Bio, Inc.
Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Health Technology |
- Beurs
- Insiders
- Stephan Kontos
- Ervaring
